UNSPSC 42142605: Medical ear syringes

In this classification, this commodity indicates a product that consists of a tube with a nozzle and piston or bulb for sucking in and ejecting liquid in a thin stream used in an ear based procedure in a medical setting. US FDA regulates Medical ear syringes under 21 CFR 874.5220 and under FDA product code KCP. Most nations, for tariff and trade purposes, schedule these products under HS 901831.

UNSPSC 42142605 Medical ear syringes is a Commodity code that captures a narrow product category, but the recent state and local solicitations tagged under this code do not reflect actual ear-syringe procurement. The opportunities posted since May 2026 span irrigation control systems (Georgia World Congress Center Authority Calsense controller upgrades, City of Pembroke Pines duplex control panel, City of Richardson traveling sprinkler equipment, and Fort Worth Housing Solutions irrigation services), occupational medical surveillance (Washington State Department of Transportation ferries medical exams), general medical supplies and equipment (Texas Health and Human Services Commission blanket purchase for the Abilene State Supported Living Center and Marion County's Vidacare EZ-IO intraosseous infusion devices), maintenance and repair supplies (City of Huntsville MRO inventory), and law enforcement equipment (Sourcewell cooperative procurement). None of these align with ear syringes as medical instruments or devices. The code shows no decision-relevant recent activity for its stated commodity.

The mismatch between code assignment and actual procurement scope indicates either upstream taxonomy misclassification in the state and local procurement systems or incidental tagging errors when opportunities are loaded into searchable databases. Firms targeting genuine ear-syringe sales to state and local health departments, hospitals, clinics, or emergency services will find this code unreliable as a market signal. Watch the code for future activity, but do not expect current opportunities to reflect genuine ear-syringe demand based on the evidence in the recent-opportunities block.